BioAtla, Inc.
BCAB
$4.54
$0.020.44%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.78M | -15.78M | -18.71M | -15.33M | -14.88M |
| Total Depreciation and Amortization | 19.00K | 56.00K | 115.00K | 183.00K | 228.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.22M | 3.41M | 1.67M | -235.00K | 1.12M |
| Change in Net Operating Assets | 634.00K | 2.43M | 2.80M | -902.00K | -3.25M |
| Cash from Operations | -7.92M | -9.88M | -14.12M | -16.29M | -16.78M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 7.13M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.00K | 0.00 | 47.00K | -- | 9.31M |
| Repurchase of Common Stock | -12.00K | -6.00K | -5.00K | -29.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -453.00K | 0.00 | -78.00K | -366.00K | -- |
| Cash from Financing | 6.71M | -6.00K | -36.00K | -395.00K | 9.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.20M | -9.89M | -14.16M | -16.68M | -7.47M |